PhilaDelic 2026 (TBD)

The Penn Psychedelics Collaborative is planning the 2026 edition of the PhilaDelic conference, expected to take place in the autumn of 2026 in Philadelphia, PA. As a recurring event at the University of Pennsylvania, it serves as a focal point for the East Coast psychedelic research community. The conference is dedicated to examining the intersection of psychedelic science, ethics, and the practicalities of healthcare implementation.

The 2026 event is anticipated to build on the success of previous forums, expanding its scope to include new clinical data and emerging trends in psychedelic law. The conference provides an environment where researchers can present their latest findings and engage in critical debate over the future of the field. It remains a vital space for connecting the local academic community with international experts and industry stakeholders.

While final dates and thematic focuses are under development, the conference will continue to prioritise high-level discourse and interdisciplinary collaboration. By maintaining a focus on rigorous academic standards, PhilaDelic 2026 aims to contribute to the responsible development of psychedelic therapies. Those interested in the academic and clinical evolution of the field are encouraged to monitor for further announcements throughout the year.